BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 180 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $959,000 | +4.2% | 8,950 | -0.0% | 0.02% | +4.2% |
Q3 2021 | $920,000 | +31.6% | 8,951 | +12.6% | 0.02% | +14.3% |
Q2 2021 | $699,000 | +421.6% | 7,950 | +448.3% | 0.02% | +250.0% |
Q3 2020 | $134,000 | -79.4% | 1,450 | -82.1% | 0.01% | -76.0% |
Q4 2019 | $649,000 | +1375.0% | 8,100 | +1250.0% | 0.02% | +1150.0% |
Q3 2019 | $44,000 | -93.9% | 600 | -93.5% | 0.00% | -95.2% |
Q3 2018 | $716,000 | +215.4% | 9,172 | +156.3% | 0.04% | +200.0% |
Q2 2018 | $227,000 | +404.4% | 3,579 | +496.5% | 0.01% | +250.0% |
Q4 2017 | $45,000 | +275.0% | 600 | +155.3% | 0.00% | +300.0% |
Q2 2017 | $12,000 | – | 235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |